View the latest clinical trials, studies, data, and updates.
Regenative Labs (will present two scientific studies demonstrating the efficacy of Wharton’s jelly allografts in complicated post-surgical wounds and late-stage sacral decubitus ulcers.
New data just published online in the prestigious journal JAMA Neurology has demonstrated the safety and efficacy of EASEE®, the world’s first minimally invasive brain pacemaker, in patients with focal epilepsy resistant to drug therapy.
“Our bioenergetic wearables are designed to communicate directly to the body, thus triggering its self-repair system,” said Harry Massey, founder and CEO of Energy4Life. “Digitized biological information allows you to help turn on the body’s self-repair system – impacting the physics of the body – which in turn directs all other activity of the body,” stated Massey.
The HYLA Blood sensor is a non-invasive optical blood sensor, being developed using machine learning based algorithms to measure blood key parameters, continuously and in real-time during extracorporeal procedures including VV-ECMO, VA-ECMO and open-heart surgery.
Dr. Hamid. “We witnessed significant and progressive reverse remodeling of the left ventricle, as well as significant and sustained improvement in quality of life and functional capacity measures. These results show promise that this innovative catheter-based therapy may help broaden options for treating patients with heart failure, and we look forward to results of the pivotal study that’s underway.”
Tom Lanman MD “The century-old ‘go-to’ procedure of fusing the spine should be a thing of the past. We strongly believe that at least half of fusions in the U.S. should never have been done in the first place. Every other joint in the body gets a replacement, and the spine should be no different.”